Cryosa

Cryosa shares news and updates about OSA treatment solutions and sleep health.

The company seeks new treatments for obstructive sleep apnea and better patient outcomes.

The company’s team includes startup entrepreneurs, engineers and medtech executives and is developing a way to treat obstructive sleep apnea.

Cryosa is a clinical-stage company developing a treatment for moderate to severe obstructive sleep apnea (OSA). It says treatment without a mask, implant, or incision may be possible.

Cryosa hosts healthcare leaders Rahul Shah and Dr. Steve Cragle to discuss its novel medical device solutions for treating moderate to severe obstructive sleep apnea. The visit focuses on Cryosa’s approach to innovation and potential partnerships in the medical device industry. The company aims to advance non-invasive treatment options for sleep apnea patients.

Feb 2026cryosa.comNews article

Cryosa develops treatments for obstructive sleep apnea (OSA) and was highlighted at the ISSS/AAOHNS conference. The company’s founder, Dr. Don Gonzales, is an otolaryngologist with prior entrepreneurial success, including founding ENTrigue (acquired by ArthroCare in 2013) and Spirox Medical (acquired by Entellus in 2017). Its emerging OSA technologies attract industry attention.

Oct 2025sleepdocs.substack.comNews article

Cryosa, Inc. treats the first U.S. patient in the **ARCTIC-3 clinical study**, testing its **Cryosa™ System** for moderate to severe obstructive sleep apnea (OSA). The company, a privately held medical device developer, evaluates the system’s efficacy in addressing a common sleep disorder affecting millions. This milestone marks progress in Cryosa’s clinical trials for OSA treatment.

Jan 2024cryosa.comNews article

Cryosa secures $21.5 million in funding to advance its medical device therapies for obstructive sleep apnea (OSA). The startup focuses on developing non-invasive treatments targeting breathing disorders during sleep.

Sep 2021Sleep ReviewNews article